Literature DB >> 25398911

Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.

Derek A Holmes1, Jung-Hua Yeh1, Donghong Yan2, Min Xu2, Andrew C Chan3.   

Abstract

Mitogen-activated protein kinase (MAPK) activation controls diverse cellular functions including cellular survival, proliferation, and apoptosis. Tuning of MAPK activation is counter-regulated by a family of dual-specificity phosphatases (DUSPs). IL-33 is a recently described cytokine that initiates Th2 immune responses through binding to a heterodimeric IL-33Rα (ST2L)/IL-1α accessory protein (IL-1RAcP) receptor that coordinates activation of ERK and NF-κB pathways. We demonstrate here that DUSP5 is expressed in eosinophils, is upregulated following IL-33 stimulation and regulates IL-33 signaling. Dusp5(-/-) mice have prolonged eosinophil survival and enhanced eosinophil effector functions following infection with the helminth Nippostrongylus brasiliensis. IL-33-activated Dusp5(-/-) eosinophils exhibit increased cellular ERK1/2 activation and BCL-XL expression that results in enhanced eosinophil survival. In addition, Dusp5(-/-) eosinophils demonstrate enhanced IL-33-mediated activation and effector functions. Together, these data support a role for DUSP5 as a novel negative regulator of IL-33-dependent eosinophil function and survival.
© 2014 Genentech Inc.

Entities:  

Keywords:  BCL‐XL; dual‐specificity phosphatase 5; eosinophil survival

Mesh:

Substances:

Year:  2014        PMID: 25398911      PMCID: PMC4337062          DOI: 10.15252/embj.201489456

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  69 in total

1.  Inhibition of NF-κB induces a switch from CD95L-dependent to CD95L-independent and JNK-mediated apoptosis in T cells.

Authors:  Michael K Kiessling; Björn Linke; Markus Brechmann; Dorothee Süss; Peter H Krammer; Karsten Gülow
Journal:  FEBS Lett       Date:  2010-10-26       Impact factor: 4.124

2.  Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling.

Authors:  Panu E Kovanen; Andreas Rosenwald; Jacqueline Fu; Elaine M Hurt; Lloyd T Lam; Jena M Giltnane; George Wright; Louis M Staudt; Warren J Leonard
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

3.  Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation.

Authors:  Joyce Y S Chow; Chun K Wong; Phyllis F Y Cheung; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

4.  Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice.

Authors:  Koubun Yasuda; Taichiro Muto; Tatsukata Kawagoe; Makoto Matsumoto; Yuki Sasaki; Kazufumi Matsushita; Yuko Taki; Shizue Futatsugi-Yumikura; Hiroko Tsutsui; Ken J Ishii; Tomohiro Yoshimoto; Shizuo Akira; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

5.  Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration.

Authors:  Jose E Heredia; Lata Mukundan; Francis M Chen; Alisa A Mueller; Rahul C Deo; Richard M Locksley; Thomas A Rando; Ajay Chawla
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

6.  Eosinophils secrete IL-4 to facilitate liver regeneration.

Authors:  Y P Sharon Goh; Neil C Henderson; Jose E Heredia; Alex Red Eagle; Justin I Odegaard; Nadja Lehwald; Khoa D Nguyen; Dean Sheppard; Lata Mukundan; Richard M Locksley; Ajay Chawla
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

Authors:  M Kopf; F Brombacher; P D Hodgkin; A J Ramsay; E A Milbourne; W J Dai; K S Ovington; C A Behm; G Köhler; I G Young; K I Matthaei
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

8.  Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies.

Authors:  Hongnga Le; Wonyoung Kim; Juyang Kim; Hong R Cho; Byungsuk Kwon
Journal:  Front Immunol       Date:  2013-05-06       Impact factor: 7.561

9.  Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Authors:  Loris R Lopetuso; Franco Scaldaferri; Theresa T Pizarro
Journal:  Fibrogenesis Tissue Repair       Date:  2012-10-14

10.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Authors:  Elisabeth H Bel; Sally E Wenzel; Philip J Thompson; Charlene M Prazma; Oliver N Keene; Steven W Yancey; Hector G Ortega; Ian D Pavord
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

View more
  24 in total

1.  The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation.

Authors:  Dan Lu; Liang Liu; Xin Ji; Yanan Gao; Xi Chen; Yu Liu; Yang Liu; Xuyang Zhao; Yan Li; Yunqiao Li; Yan Jin; Yu Zhang; Michael A McNutt; Yuxin Yin
Journal:  Nat Immunol       Date:  2015-10-19       Impact factor: 25.606

2.  Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.

Authors:  Chao Zhang; Xiaochen He; Sydney R Murphy; Huawei Zhang; Shaoxun Wang; Ying Ge; Wenjun Gao; Jan M Williams; Aron M Geurts; Richard J Roman; Fan Fan
Journal:  J Pharmacol Exp Ther       Date:  2019-05-22       Impact factor: 4.030

3.  Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.

Authors:  Andrew M Kidger; Linda K Rushworth; Julia Stellzig; Jane Davidson; Christopher J Bryant; Cassidy Bayley; Edward Caddye; Tim Rogers; Stephen M Keyse; Christopher J Caunt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-04       Impact factor: 11.205

4.  Discovery and Characterization of Halogenated Xanthene Inhibitors of DUSP5 as Potential Photodynamic Therapeutics.

Authors:  Ramani Ramchandran; Daniel S Sem; Robert D Bongard; Michael Lepley; Adam Gastonguay; Raulia R Syrlybaeva; Marat R Talipov; Rachel A Jones Lipinsky; Noah R Leigh; Jaladhi Brahmbhatt; Raman Kutty; Rajendra Rathore
Journal:  J Photochem Photobiol A Chem       Date:  2019-02-10       Impact factor: 4.291

Review 5.  A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System.

Authors:  Hai Long; Wei Liao; Ling Wang; Qianjin Lu
Journal:  Transfus Med Hemother       Date:  2016-03-18       Impact factor: 3.747

Review 6.  Role of Macrophages in the Repair Process during the Tissue Migrating and Resident Helminth Infections.

Authors:  Berenice Faz-López; Jorge Morales-Montor; Luis I Terrazas
Journal:  Biomed Res Int       Date:  2016-08-25       Impact factor: 3.411

7.  Dual Specificity Phosphatase 5 Is Essential for T Cell Survival.

Authors:  Raman G Kutty; Gang Xin; David M Schauder; Stephanie M Cossette; Michelle Bordas; Weiguo Cui; Ramani Ramchandran
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Identification of inhibitors that target dual-specificity phosphatase 5 provide new insights into the binding requirements for the two phosphate pockets.

Authors:  Terrence S Neumann; Elise A Span; Kelsey S Kalous; Robert Bongard; Adam Gastonguay; Michael A Lepley; Raman G Kutty; Jaladhi Nayak; Chris Bohl; Rachel G Lange; Majher I Sarker; Marat R Talipov; Rajendra Rathore; Ramani Ramchandran; Daniel S Sem
Journal:  BMC Biochem       Date:  2015-08-19       Impact factor: 4.059

9.  IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF.

Authors:  Ralf Willebrand; David Voehringer
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

Review 10.  The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).

Authors:  Andrew M Kidger; Stephen M Keyse
Journal:  Semin Cell Dev Biol       Date:  2016-01-11       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.